| Serial Number | 79066961 |
| Word Mark | ARK THERAPEUTICS |
| Filing Date | Friday, March 13, 2009 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Wednesday, March 13, 2019 |
| Registration Number | 3742666 |
| Registration Date | Tuesday, January 26, 2010 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 10, 2009 |
| Indication of Colors claimed | The color(s) blue and yellow is/are claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "THERAPEUTICS" |
| Description of Mark | The mark consists of an outer arc in the color blue and a concentric inner arc in the color yellow. To the right of the arcs appears the term "ARK" in the color blue over the term "THERAPEUTICS" also in blue. |
| Goods and Services | Diagnostic protein preparations for use in science, scientific diagnostics and industry; diagnostic preparations of genes for use in science, scientific diagnostics and industry |
| Goods and Services | Pharmaceutical preparations for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; pharmaceutical preparations for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; pharmaceutical preparations to promote or suppress angiogenesis and enhance blood flow; pharmaceutical preparations for increasing the efficiency of muscle cell energy production; therapeutic agents for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; therapeutic agents for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; therapeutic agents to promote or suppress angiogenesis and enhance blood flow; therapeutic agents for increasing the efficiency of muscle cell energy production; diagnostic preparations for medical purposes; protein preparations for clinical or medical laboratory use, namely for targeting therapeutic agents to specific sites; medical dressings; surgical dressings; burn dressings; wound dressings; absorbent wound and burn dressings in the nature of pads; foot and hand dressings for medical purposes; fluid handling foot and hand dressings for medical purposes; preparations of genes for therapeutics purposes namely for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; preparations of genes for therapeutic purposes namely for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; preparations of genes for therapeutic purposes namely to promote or suppress angiogenesis and enhance blood flow; preparations of genes for therapeutic purposes namely for increasing the efficiency of muscle cell energy production |
| Goods and Services | Boots and gloves for orthopaedic and medical purposes; boots and gloves for medical purposes with the ability to handle wound fluid; boots and gloves for medical use and absorbent filters, liners and inserts for use therewith; filters, soles and absorbent inserts for socks, boots and gloves for medical purposes, namely, for the treatment of wounds and burns; foot and hand dressings for medical purposes, namely, for the treatment of wounds and burns; parts and fittings for all the aforesaid goods |
| Goods and Services | Scientific, medical and clinical research, all in the field of the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting, prevention of stenosis, increasing the efficiency of muscle cell energy production and promoting or suppressing angiogenesis and enhancing blood flow; scientific, medical and clinical research for the discovery, design, creation, development and testing in the field of pharmaceutical preparations and therapeutically active substances; scientific, medical and clinical research in the field of gene therapy; scientific, medical and clinical research for the discovery, design, creation, development and testing in the field of pharmaceutical preparations and therapeutically active substances for use in the field of gene therapy; advisory services relating to the aforesaid services; scientific, medical and clinical research in the field of genes and genetics; medical and scientific research, namely, conducting gene therapy trials; provision of information relating to the above |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, September 2, 2016 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, September 2, 2016 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, September 2, 2016 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, September 2, 2016 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Ark Therapeutics Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Ark Therapeutics Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Ark Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Friday, October 11, 2019 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Friday, October 11, 2019 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, June 16, 2017 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Thursday, May 11, 2017 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Thursday, May 11, 2017 | INVALIDATION PROCESSED |
| Tuesday, May 2, 2017 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, September 2, 2016 | CANCELLED SECTION 71 |
| Thursday, February 7, 2013 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, May 24, 2010 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, May 24, 2010 | FINAL DISPOSITION PROCESSED |
| Monday, April 26, 2010 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, January 26, 2010 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 10, 2009 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 21, 2009 | NOTICE OF PUBLICATION |
| Wednesday, October 7, 2009 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, October 5, 2009 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, September 12, 2009 | AMENDMENT FROM APPLICANT ENTERED |
| Saturday, September 12, 2009 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, September 12, 2009 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Saturday, September 12, 2009 | ASSIGNED TO LIE |
| Wednesday, September 9, 2009 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, July 18, 2009 | REFUSAL PROCESSED BY IB |
| Wednesday, June 10, 2009 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, June 10, 2009 | REFUSAL PROCESSED BY MPU |
| Wednesday, June 10, 2009 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, June 9, 2009 | NON-FINAL ACTION WRITTEN |
| Friday, June 5, 2009 | ASSIGNED TO EXAMINER |
| Tuesday, April 28, 2009 | APPLICATION FILING RECEIPT MAILED |
| Friday, April 24, 2009 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, April 23, 2009 | SN ASSIGNED FOR SECT 66A APPL FROM IB |